These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3043353)

  • 21. An outbreak of gentamicin-resistant Enterobacter cloacae infections in a pediatric intensive care unit.
    Anderson EL; Hieber JP
    Infect Control; 1983; 4(3):148-52. PubMed ID: 6553023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
    Lowy FD; Wexler MA; Steigbigel NH
    J Lab Clin Med; 1982 Jul; 100(1):94-104. PubMed ID: 6919570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penicillinase-resistant penicillins plus gentamicin in experimental enterococcal endocarditis.
    Lincoln LJ; Weinstein AJ; Gallagher M; Abrutyn E
    Antimicrob Agents Chemother; 1977 Oct; 12(4):484-9. PubMed ID: 921243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria].
    Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C
    Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consistent rates of kill of Staphylococcus aureus by gentamicin over a 6-fold clinical concentration range in an in vitro pharmacodynamic model (IVPDM).
    Schafer JA; Hovde LB; Rotschafer JC
    J Antimicrob Chemother; 2006 Jul; 58(1):108-11. PubMed ID: 16735429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility of Enterobacter aerogenes and Enterobacter cloacae to 19 antimicrobial agents in vitro.
    Toala P; Lee YH; Wilcox C; Finland M
    Am J Med Sci; 1970 Jul; 260(1):41-55. PubMed ID: 4318051
    [No Abstract]   [Full Text] [Related]  

  • 28. Enoxacin compared with cefoperazone for the treatment of experimental Enterobacter aerogenes endocarditis.
    Boscia JA; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1985 May; 27(5):708-11. PubMed ID: 3860186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical isolation and characterization of aminoglycoside-resistant small colony variants of Enterobacter aerogenes.
    Rusthoven JJ; Davies TA; Lerner SA
    Am J Med; 1979 Oct; 67(4):702-6. PubMed ID: 495639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epidemiological study of a multiresistant Enterobacter cloacae causing iatrogenic infection in a surgical unit].
    Baumgartner A; Schifferli D; Spiess B
    Zentralbl Veterinarmed B; 1984 Feb; 31(1):73-7. PubMed ID: 6720166
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of netilmicin susceptibility discs using bacteria with known aminoglycoside resistance patterns: correlation of in vitro and in vivo test results.
    Waitz JA; Hare RS; Moss EL; Sabatelli FJ; Schaffer TW; Waitz JA
    Scand J Infect Dis Suppl; 1980; Suppl 23():62-72. PubMed ID: 6937970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The elimination of gentamicin-resistant gram-negative bacteria in a newborn intensive care unit.
    Raz R; Sharir R; Shmilowitz L; Kenes I; Ephros M
    Infection; 1987; 15(1):32-4. PubMed ID: 3646180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endocarditis and bacteremia caused by Enterobacter agglomerans].
    Muñoz Sanz A; García de la Llana F; Fernández Mora G; Blanco Palenciano J
    Med Clin (Barc); 1991 Mar; 96(11):436-7. PubMed ID: 2046434
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis.
    Potel G; Caillon J; Le Gallou F; Bugnon D; Le Conte P; Raza J; Lepage JY; Baron D; Drugeon H
    Antimicrob Agents Chemother; 1992 Apr; 36(4):744-50. PubMed ID: 1503436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of difloxacin, enoxacin, and cefoperazone for treatment of experimental Enterobacter aerogenes endocarditis.
    Boscia JA; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1987 Mar; 31(3):458-60. PubMed ID: 3472489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transferable gentamicin resistance in Enterobacter cloacae.
    Poston SM; Aubrey C; Cameron JM
    J Antimicrob Chemother; 1976 Jun; 2(2):189-94. PubMed ID: 783111
    [No Abstract]   [Full Text] [Related]  

  • 37. Standardization of a rapid microbiologic assay for aminoglycosides using Enterobacter cloacae.
    Stevens DL; Page BM; Adeniyi-Jones C
    Am J Clin Pathol; 1978 Nov; 70(5):808-15. PubMed ID: 717287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serratia marcescens endocarditis: successful carbenicillin and gentamicin treatment.
    Farhoudi HO; Banks T; Ali N
    Ann Intern Med; 1973 May; 78(5):776-7. PubMed ID: 4576206
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapy of experimental infective endocarditis due to antibiotic-tolerant Lactobacillus plantarum-bactericidal synergy of penicillin plus gentamicin. Correlation of in vitro susceptibility studies with in vivo efficacy.
    Bayer AS; Chow AW; Ishida K; Morrison JO; Guze LB
    Chemotherapy; 1981; 27(6):444-51. PubMed ID: 6913466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enterobacter cloacae ventriculitis successfully treated with cefepime and gentamicin: case report and review of the literature.
    Barnes BJ; Wiederhold NP; Micek ST; Polish LB; Ritchie DJ
    Pharmacotherapy; 2003 Apr; 23(4):537-42. PubMed ID: 12680484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.